<DOC>
	<DOCNO>NCT00369538</DOCNO>
	<brief_summary>Chronic glomerular diseases one main cause leading end stage renal disease ( ESRD ) . Hypertension proteinuria two modifiable factor promote progression ESRD . Podocyte terminally differentiate epithelial cell play central role progression chronic kidney disease development glomerulosclerosis . The presence podocyte urine ( podocyturia ) document several team continuous regular podocyturia glomerular disease . This facts suggest podocyturia could become marker podocyte loss glomerular damage . In university hospital , develop technique evaluate number microparticles ( cellular fragment ) different biologic sample . The podocytary origin microparticles determinated thanks specific antibody . The aim present study : ) quantify podocyturia glomerular nephropathy dose podocyte microparticles ii ) study relationship podocyturia biologic marker proteinuria iii ) evaluate effect angiotensine 2 blockage podocyturia . This open-labelled randomized monocenter cross-over study . Twenty subject hypertension glomerular nephropathy characterize proteinuria normal slightly alter renal function include . Patients treat successively angiotensin receptor blocker ( ARB ) , losartan thiazide , hydrochlorothiazide , ( wash period ) . We study impact two therapy podocyturia . Results compare others marker like proteinuria ( selectivity ) . We may finally dispose non invasive urinary marker podocyte lesion responsible glomerulosclerosis ESRD progression . Moreover mechanism nephroprotection ARB may comprehensive .</brief_summary>
	<brief_title>Specific Blockage Angiotensine 2 Podocyturia Glomerular Nephropathies With Hypertension Proteinuria</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<mesh_term>Angiotensin II</mesh_term>
	<criteria>Hypertension ( TAs &gt; 130 , TAd &gt; 80mmHg antihypertensive treatment ) Glomerular nephropathy , proteinuria &gt; 1 g/day , serum creatinin &lt; 200 Âµmol/L ; Informed consent give ; No contraindication ARB hydrochlorothiazide ; Efficient contraception woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Podocyte - podocyturia - microparticles - angiotensin receptor antagonist - glomerulosclerosis</keyword>
	<keyword>Patients present stable glomerular nephropathy proteinuria , normal slightly alter renal function , hypertension</keyword>
</DOC>